Carolin S. Escherich

Duesseldorf, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results.

Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 30, 2025

Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicin.

Differentiation-dependent EBF1 activity determines CD22 transcription and leukemia sensitivity to inotuzumab ozogamicin.

Journal: Blood
Published: December 30, 2024

DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemia.

DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemia.

Journal: Blood
Published: July 08, 2024

Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children.

Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children.

Journal: Blood
Published: November 20, 2023

Germline Genetic NBN Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in Children.

Germline Genetic NBN Variation and Predisposition to B-cell Acute Lymphoblastic Leukemia in Children.

Journal: Research square
Published: July 28, 2023

Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia.

Identification of TCF3 germline variants in pediatric B-cell acute lymphoblastic leukemia.

Journal: Blood advances
Published: July 04, 2022

The Growing Spectrum of DADA2 Manifestations-Diagnostic and Therapeutic Challenges Revisited.

The Growing Spectrum of DADA2 Manifestations-Diagnostic and Therapeutic Challenges Revisited.

Journal: Frontiers in pediatrics
Published: February 28, 2022

Mucha-Habermann disease: a pediatric case report and proposal of a risk score.

Mucha-Habermann disease: a pediatric case report and proposal of a risk score.

Journal: International journal of dermatology
Published: December 01, 2020
Showing 1-8 of 8

Last Updated: 09/26/2026